Home > Financial Ratios > MARKSANS PHARMA

MARKSANS PHARMA
Working Capital/Sales

    Back to All Ratios
MARKSANS PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
AD     Remove this Ad

MARKSANS PHARMA Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Working Capital/Sales(x) 1.591.551.531.832.30

What is the latest Working Capital/Sales ratio of MARKSANS PHARMA ?

The latest Working Capital/Sales ratio of MARKSANS PHARMA is 1.59 based on Mar2025 Consolidated results.
Year Working Capital/Sales
Mar20251.59
Mar20241.55
Mar20231.53
Mar20221.83
Mar20212.30

How is Working Capital/Sales of MARKSANS PHARMA Trending?

Years Working Capital/Sales % Change
Mar2025 1.59
2.58
Mar2024 1.55
1.31
Mar2023 1.53
-16.39
Mar2022 1.83
-20.43
Mar2021 2.3 -

Other Financial Ratios of MARKSANS PHARMA


Compare Working Capital/Sales ratio of peers of MARKSANS PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MARKSANS PHARMA ₹7,122.0 Cr -1.7% -10.5% -28.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹421,647.0 Cr 0.1% -0.4% 0.6% Stock Analytics
DIVIS LABORATORIES ₹157,862.0 Cr -1.1% -7.1% 1.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹142,846.0 Cr 0.2% -4.5% 30.9% Stock Analytics
DR REDDYS LABORATORIES ₹104,720.0 Cr 0.2% -4% 6% Stock Analytics
CIPLA ₹98,795.9 Cr 0% -9.1% -18.5% Stock Analytics


MARKSANS PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MARKSANS PHARMA

-1.7%

-10.5%

-28.7%

SENSEX

-3.5%

-12.5%

-6.5%


You may also like the below Video Courses